BioSign

CHARM as in "cardio-hemodynamic autonomous response to medication" – the object of Biosign’s upcoming UFIT service, intended to help people monitor the safety, efficacy, and adequacy of their health care.

Tags: technologies, products, global, chronic diseases, hypertension, diabetes, e-Lab, vital signs, digital signal, patients, physicians, pharmacists, payors, pharmaceutical, non-invasive, integrated, portable, innovation, safe, simple

BioSign
230-175 Commerce Valley Drive West
Thornhill
ON
L3T 7P6
Canada